|
1) Adcock IM, Tsaprouni L, Bhavsar L, et al. Epigenetic regulation of airway inflammation. Curr Opin Immunol. 2007; 19: 694-700
|
|
|
|
2) Franceschi C, Capri M, Monti D, et al. Inflamm-aging and anti-inflammaging: a systemic per-spective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007; 128: 92-105
|
|
|
|
|
|
3) Nakamaru Y, Vuppusetty C, Wada H, et al. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J. 2009; 23: 2810-9
|
|
|
|
|
|
4) Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005; 352: 1967-76
|
|
|
|
|
|
5) Cosgrove MS, Wolberger C. How does the histone code work？ Biochem Cell Biol. 2005; 83: 468-76
|
|
|
|
|
|
6) Shames DS, Minna JD, Gazdar AF. DNA methyl-ation in health, disease, and cancer. Curr Mol Med. 2007; 7: 85-102
|
|
|
|
|
|
7) Adcock IM, Ito K, Barnes PJ. Histone deacetyl-ation: an important mechanism in inflammatory lung diseases. COPD. 2005; 2: 445-55
|
|
|
|
|
|
8) Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000; 20: 6891-903
|
|
|
|
|
|
9) Matthews JG, Ito K, Barnes PJ, et al. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in gluco-corticoid-resistant patients. J Allergy Clin Immunol. 2004; 113: 1100-8
|
|
|
|
|
|
10) Zhang Y, Fang H, Jiao J, et al. The structure and function of histone deacetylases: the target for anti-cancer therapy. Curr Med Chem. 2008; 15: 2840-9
|
|
|
|
|
|
11) Franceschi C, Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans. 2003; 31: 457-61
|
|
|
|
|
|
12) Ito K, Barnes PJ. COPD as a disease of acceler-ated lung aging. Chest. 2009; 135: 173-80
|
|
|
|
|
|
13) Ishii M, Yamaguchi Y, Yamamoto H, et al. Airspace enlargement with airway cell apoptosis in Klotho mice: a model of aging lung. J Gerontol A Biol Sci Med Sci. 2008; 63: 1289-98
|
|
|
|
|
|
14) Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med. 2006; 174: 530-7
|
|
|
|
|
|
15) Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460: 392-5
|
|
|
|
|
|
16) Harms KL, Chen X. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity. Cancer Res. 2007; 67: 3145-52
|
|
|
|
|
|
17) Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008; 8: 157-68
|
|
|
|
|
|
18) Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007; 404: 1-13
|
|
|
|
|
|
19) Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004; 114: 1248-59
|
|
|
|
|
|
20) Suzuki M, Betsuyaku T, Ito Y, et al. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2008; 39: 673-82
|
|
|
|
|
|
21) Malhotra D, Thimmulappa R, Navas-Acien A, et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med. 2008; 178: 592-604
|
|
|
|
|
|
22) Marwick JA, Ito K, Adcock IM, et al. Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy. Expert Opin Ther Targets. 2007; 11: 745-55
|
|
|
|
|
|
23) Moonen HJ, Geraets L, Vaarhorst A, et al. Theophylline prevents NAD＋ depletion via PARP-1 inhibition in human pulmonary epithelial cells. Biochem Biophys Res Commun. 2005; 338: 1805-10
|
|
|
|
|